BioVie (BIVI) CFO raises holdings to 3,441 shares

Rhea-AI Filing Summary

BIOVIE INC. (BIVI) reported that its Chief Financial Officer, Joanne Wendy Kim, purchased 2,500 shares of common stock in an open market transaction on 2026-08-28 at a price of $2.18 per share. Following this purchase, she directly holds 3,441 shares of BIOVIE INC. common stock.

Insider Trade Summary

Net Buyer: 2,500 shares

Net Buy 1 txn

Insider KIM JOANNE WENDY

Role Chief Financial Officer

Bought 2,500 shs ($5K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1	2,500	$2.18	$5K

Holdings After Transaction: Common Stock — 3,441 shares (Direct)

Footnotes (1)

1. F1. The shares of Common Stock were purchased by the Reporting Person in an open market transaction.

Key Figures

Shares purchased: 2,500 shares of Common Stock Purchase price per share: $2.18 per share Shares owned after transaction: 3,441 shares of Common Stock

3 metrics

Shares purchased 2,500 shares of Common Stock Open market purchase on 2026-08-28

Purchase price per share $2.18 per share Open market transaction by CFO on 2026-08-28

Shares owned after transaction 3,441 shares of Common Stock Direct holdings of CFO Joanne Wendy Kim following the purchase

Key Terms

open market transaction, Common Stock, Form 4

3 terms

open market transaction financial

"shares of Common Stock were purchased by the Reporting Person in an open market transaction"

An open market transaction is a buy or sell of publicly traded securities executed on an exchange or other public trading venue where many buyers and sellers can participate. It matters to investors because these trades change the visible supply and demand for a stock—like shoppers moving prices in a busy marketplace—affecting share price, liquidity (how easily you can trade), and sometimes the balance of ownership.

Common Stock financial

"security_title: Common Stock; shares of Common Stock were purchased"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

What insider transaction did BIVI disclose in this Form 4?

BIOVIE INC. disclosed that Chief Financial Officer Joanne Wendy Kim purchased 2,500 shares of common stock in an open market transaction on 2026-08-28 at $2.18 per share, increasing her direct holdings to 3,441 shares.

How many BIVI shares did CFO Joanne Wendy Kim buy and at what price?

CFO Joanne Wendy Kim bought 2,500 shares of BIOVIE INC. common stock at a price of $2.18 per share in an open market purchase dated 2026-08-28.

What are CFO Joanne Wendy Kim’s BIVI holdings after this transaction?

After the reported purchase, CFO Joanne Wendy Kim directly holds 3,441 shares of BIOVIE INC. common stock, as stated in the Form 4 filing.

Was the BIVI insider trade made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not checked, and a footnote states the shares were purchased in an open market transaction, not described as pursuant to a trading plan.

What type of security did the BIVI insider purchase?

The insider purchased Common Stock of BIOVIE INC., as identified in the Form 4 transaction details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/28/2026 - 08:58 PM Accepted by SEC EDGAR 08/28/2026 - 08:58 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KIM JOANNE WENDY

(Last) (First) (Middle)

C/O BIOVIE INC.

680 W NYE LANE STE 201

(Street)

CARSON CITY NEVADA 89703

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BIOVIE INC. [ BIVI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/28/2026		P		2,500(1)	A	$2.18	3,441	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares of Common Stock were purchased by the Reporting Person in an open market transaction.

	/s/ Joanne Wendy Kim	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)